Core Viewpoint - The company is undergoing a comprehensive strategic transformation from traditional imaging services to "smart imaging + data ecology + internationalization" driven by the surge in global health demand and advancements in AI and big data technologies [1] Group 1: Business Model and Services - The company has established a complete medical imaging ecosystem through three main business segments: "imaging center services + imaging solution services + Yimai Cloud services," aiding hospitals in achieving precise medical upgrades [1] - By the end of 2024, the company will operate 106 imaging centers across 16 provinces in China, forming a robust business system [1] Group 2: Collaborations and Partnerships - The company is advancing digital transformation and intelligent upgrades in the medical imaging field through deep collaborations with major firms like Huawei, signing comprehensive cooperation agreements to focus on medical imaging [2][3] - Strategic partnerships have been formed with various entities, including a collaboration with iFlytek Medical to explore joint market development and AI diagnostic model research [2][3] Group 3: Market Position and Opportunities - The Chinese medical imaging market has surpassed 100 billion, with uneven distribution of imaging resources in public hospitals, creating opportunities for the company to empower county hospitals and optimize resource utilization [4] - The company is expanding into specialized markets such as neurodegenerative diseases and early cancer screening, which are experiencing rapid growth in demand for high-precision imaging [4] Group 4: International Expansion - The company has established a solid foundation for internationalization through years of experience and brand influence in the domestic market [5] - A strategic partnership was formed with Hong Kong Medical Health to create a "central procurement + global distribution" supply chain platform, marking a significant step towards global expansion [5][6] - The company has set up an overseas division in 2024, targeting regions such as Hong Kong, Macau, Southeast Asia, the Middle East, and Africa, aiming to build a global business network [6]

Group 1 - Company announced a placement agreement with agents including CITIC Securities, Guotai Junan International, and TradeGo Markets to facilitate the sale of 9.75 million shares at a price of HKD 20.00 per share [1] - The placement shares represent approximately 3.91% of the existing issued H shares and about 2.74% of the total issued shares as of the announcement date [1] - If all placement shares are fully subscribed, the total proceeds are expected to be approximately HKD 195 million, with a net amount of about HKD 182 million [2] Group 2 - The net proceeds from the placement will be allocated as follows: approximately 50% (HKD 91.15 million) for business investments and acquisitions, 25% (HKD 45.57 million) for overseas business expansion, 15% (HKD 27.34 million) for data and research, and 10% (HKD 18.23 million) for general working capital [2]